Technical
Channels

Drug Discovery

Drug Development

Drug Manufacturing

Drug Delivery

Clinical Trials

Regulatory and Legal

Alliances and Mergers

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Change text size [+] [-]

ABLE - Elsevier Partnership to Boost Research for Indian SMEs

Friday, July 10, 2009
 Email This |  Printer Friendly

The partnership between the Association of Biotechnology Led Enterprises (ABLE) and Elsevier will provide a boost to the innovation efforts of Biotech SME (Small and medium enterprise) members of the former.

In June, groups of biotech SMEs met for the launch of the partnership in Bangalore. This partnership is about making available online, copyright cleared scientific content from Elsevier to the researchers at their desktops, in a timely and cost-effective manner, which is essential to R&D.

Shrikumar Suryanarayan, director general, ABLE said, "Biotech SME's have always needed the scientific information, but did not have resources for accessing it. Through the partnership, Elsevier's scientific information resources like ScienceDirect and Scopus will be made available to SME members of the association at a special price."


Share this:   Del.icio.us | 
Digital Edition



Singapore's Preclinical R&D industry should differentiate itself in Asia by competing on quality rather than on price.
Yes
No
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2010 Ten Alps Communications Asia. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy